Free Trial

Elevation Oncology (ELEV) Earnings Date, Estimates & Call Transcripts

Elevation Oncology logo
$0.38 +0.01 (+1.83%)
Closing price 04:00 PM Eastern
Extended Trading
$0.38 0.00 (-1.00%)
As of 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Elevation Oncology Earnings Summary

Upcoming
Earnings Date
May. 1Before Market OpensEstimated
Consensus EPS
(Mar. 6)
-$0.22
Actual EPS
(Mar. 6)
-$0.18 Beat By $0.04

Elevation Oncology posted Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.18, which beat the consensus estimate of -$0.22 by $0.04. With a trailing EPS of -$0.81, Elevation Oncology's earnings are expected to decrease next year, from ($0.84) to ($0.89) per share.

Q4 2024 Earnings Resources

ELEV Upcoming Earnings

Elevation Oncology's Q1 2025 earnings is scheduled for Thursday, May 1, 2025, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Elevation Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevation Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ELEV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Elevation Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20253-$0.27-$0.21-$0.24
Q2 20254-$0.29-$0.20-$0.23
Q3 20254-$0.23-$0.19-$0.21
Q4 20254-$0.24-$0.20-$0.22
FY 202515($1.03)($0.80)($0.90)

Elevation Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/1/2025
(Estimated)
-------
3/6/2025Q4 2024-$0.22-$0.18+$0.04-$0.18--
11/6/2024--$0.20-$0.22 -$0.02-$0.22--
8/6/2024--$0.23-$0.18+$0.05-$0.18--
5/2/2024Q1 2024-$0.21-$0.23 -$0.02-$0.23--
3/6/2024Q4 2023-$0.21-$0.19+$0.02-$0.19--
11/2/2023Q3 2023-$0.34-$0.25+$0.09-$0.25--
8/3/2023Q2 2023-$0.28-$0.37 -$0.09-$0.37--
5/15/2023Q1 2023-$0.51-$0.50+$0.01-$0.28--

Elevation Oncology Earnings - Frequently Asked Questions

Elevation Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on ELEV's earnings history.

In the previous quarter, Elevation Oncology (NASDAQ:ELEV) reported ($0.18) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.22) by $0.04. Learn more on analysts' earnings estimate vs. ELEV's actual earnings.

Elevation Oncology (NASDAQ:ELEV) has a recorded net income of -$45.70 million. ELEV has generated -$0.81 earnings per share over the last four quarters.

Elevation Oncology's earnings are expected to decrease from ($0.84) per share to ($0.89) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ELEV) was last updated on 4/23/2025 by MarketBeat.com Staff
From Our Partners